by The global allergy diagnostics and therapeutics market size was approximate at US$ 31.64 billion in 2022 and is anticipated to grow US$ 31.64 billion by 2032, registering a compound annual growth rate of 6.89% from 2023 to 2032.
The allergy diagnostics and therapeutics market report covering various industry elements and growth trends helpful for predicting the market’s future.
The study provides a strong base for the allergy diagnostics and therapeutics market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2032.
This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2023 g0066ztr to 2032. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the allergy diagnostics and therapeutics report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the allergy diagnostics and therapeutics market have been studied and analysed across many developments.
Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2991
Allergy Diagnostics and Therapeutics Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 33.82 Billion |
| Market Size by 2032 | USD 61.60 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 6.89% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Product, By Drug Class, By Test, By Allergen Type, and By End-user |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Also read: Digital Breast Tomosynthesis Equipment Market Size Forecast 2032
Research Approach
The comprehensive report on the global allergy diagnostics and therapeutics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global allergy diagnostics and therapeutics market.
It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Key Players
- R-Biopharm AG
- EUROIMMUN Medizinische Labordiagnostika AG
- DASIT Group SPA
- bioMérieux
- Thermo Fisher Scientific, Inc.
- Stallergenes Greer
- Sun Pharmaceutical Industries Ltd
- Minaris Medical America, Inc.
- Siemens Healthcare GmbH
- AESKU.GROUP GmbH
- Omega Diagnostics Group PLC
- HYCOR Biomedical
- Lincoln Diagnostics, Inc.
- Alcon
- Astellas Pharma Inc.
- HOB Biotech Group Corp., Ltd.
- Danaher
- AbbVie, Inc.
- Allergy Therapeutics
- Sanofi
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- GSK plc
- F. Hoffmann-La Roche Ltd.
- Merck & Co., Inc.
Allergy Diagnostics and Therapeutics Market Segmentations
By Product
- Instruments
- Consumables
- Services
By Drug Class
- Nasal Anti-cholinergic
- Antihistamines
- Corticosteroids
- Mast Cell Stabilizers
- Leukotriene Inhibitors
- Epinephrine
- Immunotherapy
- Decongestants
- Immuno-modulators
By Test
- In vivo Test
- In vitro Test
By Allergen Type
- Food
- Inhaled
- Drug
- Other Allergens
By End-user
- Hospitals
- Diagnostics Labs
- Research & Development Centers
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Allergy Diagnostics and Therapeutics Market
5.1. COVID-19 Landscape: Allergy Diagnostics and Therapeutics Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Allergy Diagnostics and Therapeutics Market, By Product
8.1. Allergy Diagnostics and Therapeutics Market, by Product, 2023-2032
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Consumables
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Allergy Diagnostics and Therapeutics Market, By Drug Class
9.1. Allergy Diagnostics and Therapeutics Market, by Drug Class, 2023-2032
9.1.1. Nasal Anti-cholinergic
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Antihistamines
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Corticosteroids
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Mast Cell Stabilizers
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Leukotriene Inhibitors
9.1.5.1. Market Revenue and Forecast (2020-2032)
9.1.6. Epinephrine
9.1.6.1. Market Revenue and Forecast (2020-2032)
9.1.7. Immunotherapy
9.1.7.1. Market Revenue and Forecast (2020-2032)
9.1.8. Decongestants
9.1.8.1. Market Revenue and Forecast (2020-2032)
9.1.9. Immuno-modulators
9.1.9.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Allergy Diagnostics and Therapeutics Market, By Test
10.1. Allergy Diagnostics and Therapeutics Market, by March, 2023-2032
10.1.1. In vivo Test
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. In vitro Test
10.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Allergy Diagnostics and Therapeutics Market, By By Allergen Type
11.1. Allergy Diagnostics and Therapeutics Market, by By Allergen Type, 2023-2032
11.1.1. Food
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Inhaled
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Drug
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Other Allergens
11.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Allergy Diagnostics and Therapeutics Market, By End-user
12.1. Allergy Diagnostics and Therapeutics Market, by End-user, 2023-2032
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Diagnostics Labs
12.1.2.1. Market Revenue and Forecast (2020-2032)
12.1.3. Research & Development Centers
12.1.3.1. Market Revenue and Forecast (2020-2032)
12.1.4. Others
12.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 13. Global Allergy Diagnostics and Therapeutics Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2020-2032)
13.1.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.1.3. Market Revenue and Forecast, by Test(2020-2032)
13.1.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.1.5. Market Revenue and Forecast, by End-user (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.1.6.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.1.6.3. Market Revenue and Forecast, by Test(2020-2032)
13.1.6.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.1.6.5. Market Revenue and Forecast, by End-user (2020-2032)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product (2020-2032)
13.1.7.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.1.7.3. Market Revenue and Forecast, by Test(2020-2032)
13.1.7.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.1.7.5. Market Revenue and Forecast, by End-user (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.2.3. Market Revenue and Forecast, by Test(2020-2032)
13.2.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.2.5. Market Revenue and Forecast, by End-user (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.6.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.2.6.3. Market Revenue and Forecast, by Test(2020-2032)
13.2.7. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.2.8. Market Revenue and Forecast, by End-user (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.9.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.2.9.3. Market Revenue and Forecast, by Test(2020-2032)
13.2.10. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.2.11. Market Revenue and Forecast, by End-user (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.12.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.2.12.3. Market Revenue and Forecast, by Test(2020-2032)
13.2.12.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.2.13. Market Revenue and Forecast, by End-user (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.14.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.2.14.3. Market Revenue and Forecast, by Test(2020-2032)
13.2.14.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.2.15. Market Revenue and Forecast, by End-user (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.3.3. Market Revenue and Forecast, by Test(2020-2032)
13.3.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.3.5. Market Revenue and Forecast, by End-user (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.6.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.3.6.3. Market Revenue and Forecast, by Test(2020-2032)
13.3.6.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.3.7. Market Revenue and Forecast, by End-user (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.8.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.3.8.3. Market Revenue and Forecast, by Test(2020-2032)
13.3.8.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.3.9. Market Revenue and Forecast, by End-user (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.10.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.3.10.3. Market Revenue and Forecast, by Test(2020-2032)
13.3.10.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.3.10.5. Market Revenue and Forecast, by End-user (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.11.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.3.11.3. Market Revenue and Forecast, by Test(2020-2032)
13.3.11.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.3.11.5. Market Revenue and Forecast, by End-user (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.4.3. Market Revenue and Forecast, by Test(2020-2032)
13.4.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.4.5. Market Revenue and Forecast, by End-user (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.6.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.4.6.3. Market Revenue and Forecast, by Test(2020-2032)
13.4.6.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.4.7. Market Revenue and Forecast, by End-user (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.8.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.4.8.3. Market Revenue and Forecast, by Test(2020-2032)
13.4.8.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.4.9. Market Revenue and Forecast, by End-user (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.10.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.4.10.3. Market Revenue and Forecast, by Test(2020-2032)
13.4.10.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.4.10.5. Market Revenue and Forecast, by End-user (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.11.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.4.11.3. Market Revenue and Forecast, by Test(2020-2032)
13.4.11.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.4.11.5. Market Revenue and Forecast, by End-user (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2020-2032)
13.5.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.5.3. Market Revenue and Forecast, by Test(2020-2032)
13.5.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.5.5. Market Revenue and Forecast, by End-user (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.5.6.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.5.6.3. Market Revenue and Forecast, by Test(2020-2032)
13.5.6.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.5.7. Market Revenue and Forecast, by End-user (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2020-2032)
13.5.8.2. Market Revenue and Forecast, by Drug Class (2020-2032)
13.5.8.3. Market Revenue and Forecast, by Test(2020-2032)
13.5.8.4. Market Revenue and Forecast, by By Allergen Type (2020-2032)
13.5.8.5. Market Revenue and Forecast, by End-user (2020-2032)
Chapter 14. Company Profiles
14.1. R-Biopharm AG
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. EUROIMMUN Medizinische Labordiagnostika AG
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. DASIT Group SPA
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. bioMérieux
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Thermo Fisher Scientific, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Stallergenes Greer
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Sun Pharmaceutical Industries Ltd
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Minaris Medical America, Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Siemens Healthcare GmbH
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. AESKU.GROUP GmbH
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global allergy diagnostics and therapeutics market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for allergy diagnostics and therapeutics are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2023-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
